TRIM52: A nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway

被引:31
作者
Fan, Wenchun [1 ,2 ]
Liu, Tingting [1 ,2 ]
Li, Xiangmin [1 ,2 ,3 ]
Zhou, Yun [1 ,2 ]
Wu, Mengge [1 ,2 ]
Cui, Xiaofang [1 ,2 ]
Chen, Huanchun [1 ,2 ,3 ]
Qian, Ping [1 ,2 ,3 ]
机构
[1] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei Province, Peoples R China
[2] Huazhong Agr Univ, Div Anim Infect Dis, Coll Vet Med, Wuhan 430070, Peoples R China
[3] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
TRIM52; Nuclear factor-kappa B (NF-kappa B); Signaling transduction; Pro-inflammatory cytokine; FAMILY PROTEINS; INNATE IMMUNITY; AUTOPHAGY; CANCER; DEGRADATION; ACTIVATION; DISEASE; LIGASES; ROLES; ALPHA;
D O I
10.1016/j.molimm.2017.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence suggests that TRIM family proteins play a crucial role in regulating the NF-kappa B signaling pathway. TRIM52 is a novel noncanonical antiviral TRIM gene with a unique expanded RING domain. Information on the biological function of TRIM52 is limited. Herein, we demonstrated TRIM52 involvement in NF-kappa B activation. We found that TRIM52 overexpression specifically activated the NF-kappa B signal. TRIM52 overexpression can significantly induce TNF alpha and IL-6 expression. We also found that the RING domain of TRIM52 was essential for its activation of the NF-kappa B signal. Further study showed that TRIM52 overexpression did not affect the protein level of I kappa B alpha and phosphorylated p65 protein. We found that the pro-inflammatory cytokines TNF alpha and IL-6 could induce TRIM52 expression. Overall, these data suggested that TRIM52 was a positive regulator of the NF-kappa B pathway. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 43 条
  • [1] Amini-bavil-olyaee S., 2014, NAT COMMUN, V5, P4820
  • [2] RETRACTED: Regulation of activity and function of the p52 NF-κB subunit following DNA damage (Retracted article. See vol. 13, pg. 2312, 2014)
    Barre, Benjamin
    Coqueret, Olivier
    Perkins, Neil D.
    [J]. CELL CYCLE, 2010, 9 (24) : 4795 - 4804
  • [3] The two NF-κB activation pathways and their role in innate and adaptive immunity
    Bonizzi, G
    Karin, M
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (06) : 280 - 288
  • [4] Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease
    Brynskov, J
    Foegh, P
    Pedersen, G
    Ellervik, C
    Kirkegaard, T
    Bingham, A
    Saermark, T
    [J]. GUT, 2002, 51 (01) : 37 - 43
  • [5] Human TRIM Gene Expression in Response to Interferons
    Carthagena, Laetitia
    Bergamaschi, Anna
    Luna, Joseph M.
    David, Annie
    Uchil, Pradeep D.
    Margottin-Goguet, Florence
    Mothes, Walther
    Hazan, Uriel
    Transy, Catherine
    Pancino, Gianfranco
    Nisole, Sebastien
    [J]. PLOS ONE, 2009, 4 (03):
  • [6] Egan L, 2009, REV SYST BIOL MED, V1, P107
  • [7] TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A
    Fan, Wenchun
    Wu, Mengge
    Qian, Suhong
    Zhou, Yun
    Chen, Huanchun
    Li, Xiangmin
    Qian, Ping
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [8] Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism
    Fan, Wenchun
    Zhang, Dong
    Qian, Ping
    Qian, Suhong
    Wu, Mengge
    Chen, Huanchun
    Li, Xiangmin
    [J]. ANTIVIRAL RESEARCH, 2016, 127 : 32 - 40
  • [9] Early evidence for the role of TRIM29 in multiple cancer models
    Hatakeyama, Shigetsugu
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (07) : 767 - 770
  • [10] TRIM proteins and cancer
    Hatakeyama, Shigetsugu
    [J]. NATURE REVIEWS CANCER, 2011, 11 (11) : 792 - 804